Latest Breaking News On - Mike favet - Page 1 : vimarsana.com

NeuroPace Announces CEO Transition

NeuroPace Appoints Joel Becker as President & CEO Becker Brings a Track Record of Strong Commercial Execution and Deep Medical Device Operating Expertise Mike Favet to leave Company after four years as President, CEO and Board Member and will contin.

Frank fischerJoel beckerJeremy fefferMike favetMichael favetInteger holdingsAtrial fibrillation divisionExchange commissionCarlson school of managementUniversity of minnesotaJude medical incMaster of business administrationNeuropace incAmericas divisionNeuropace appoints joel beckerTrack record

NeuroPace Announces Addition of Kelley Nicholas as Vice President, Sales

To focus on commercial growth, including expanding adoption and driving higher utilization of NeuroPace’s RNS SystemMOUNTAIN VIEW, Calif., May 24, 2023 NeuroPace, Inc. , a commercial-stage. | June 11, 2023

Mike favetKelley nicholasHealth science physical therapyUniversity of missouriNeuropace incExchange commissionWashington university in stVice presidentChief executive officerGlobal vice presidentCommercial operationsThermo fisher scientificChemical analysisIntuitive surgicalPower medicalHealth science

NeuroPace, Inc (NASDAQ:NPCE) Q1 2023 Earnings Call Transcript

Operator: Good afternoon, and welcome to NeuroPace s First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

United statesMike favetRebecca kuhnMichael favetMichael polarkRobbie marcusFrank takkinenGilmartin groupEpilepsy centersWolfe researchNeuropace incJp morganCall transcript mayFirst quarter earnings conferenceTrip taylorFederal securities laws

NeuroPace, Inc (NASDAQ:NPCE) Q4 2022 Earnings Call Transcript

Operator: Good afternoon, and welcome to NeuroPace s Fourth Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.

United statesMichael favetMike favetMichael polarkRebecca kuhnGilmartin groupWolfe researchNeuropace incCall transcript marchFourth quarter earnings conferenceTrip taylorFederal securities lawsPrivate securities litigation reform actRisk factorsHigh returnsPort terminal operators

NeuroPace (NPCE) Reports Prelim Q4 Revenue of $12 8M, Appoints Uri Geiger to its Board

NeuroPace (NPCE) Reports Prelim Q4 Revenue of $12 8M, Appoints Uri Geiger to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMike favetPhilip taylorGalayor networksTel aviv university recanati school of businessEpilepsy foundationStartup companiesExchange commissionYork columbia university centerGilmartin groupDragon variation fundNeuropace incExalenz bioscience ltdUri geigerUnaudited fourth quarterUnaudited full year